Healthcare provider currently forecasting a £15.2m overspend
Increased spend on drugs over the winter months poses a 'huge pressure' to Manx Care's finances.
That's according to the healthcare provider's finance director who provided an update on the organisation's finances at the most recent board meeting.
Earlier this year Manx Care was forecasting an overspend in excess of £18m but its most recent figures show that now stands at £15.2m.
Jackie Lawless says medication is one area that can see rising demand and therefore higher costs at this time of year:
Tynwald's Auditor General publishes annual report
Public warned of increased risk of wildfires
Cocaine, ketamine and cannabis dealer jailed
Assisted Dying Bill mover pleased as Jersey becomes first place in British Isles to legalise assisted deaths
